NCT06679075View on ClinicalTrials.gov

Clinical and Radiographic Evaluation of Propolis As a Hemostatic Agent for Pulpotomy of Mature Permanent Molars with Irreversible Pulpitis Using Two Different Dressing Materials

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

February 28, 2026

Conditions
Irreversible PulpitisPulpitisPulpitis - Irreversible
Interventions
PROCEDURE

Full pulpotomy using propolis and bioceramic putty

Full Pulpotomy for participants with mature adult molars diagnosed with irreversible pulpitis; using Propolis as a hemostatic agent and bioceramic putty as a dressing material

PROCEDURE

Full pulpotomy using Propolis and MTA

Full Pulpotomy for participants with mature adult molars diagnosed with irreversible pulpitis; using Propolis as a hemostatic agent and MTA as a dressing material

PROCEDURE

Full pulpotomy using sodium hypochlorite and bioceramic putty

Full Pulpotomy for participants with mature adult molars diagnosed with irreversible pulpitis; using sodium hypochlorite (NaOCl) as a hemostatic agent and bioceramic putty as a dressing material

PROCEDURE

Full pulpotomy using sodium hypochlorite and MTA

Full Pulpotomy for participants with mature adult molars diagnosed with irreversible pulpitis; using sodium hypochlorite (NaOCl) as a hemostatic agent and MTA as a dressing material.

Trial Locations (1)

23726

Misr International University, Cairo

All Listed Sponsors
lead

Misr International University

OTHER